91 related articles for article (PubMed ID: 11014575)
1. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
2. Expression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.
Nikas IP; Park SY; Song MJ; Lee C; Ryu HS
Diagn Cytopathol; 2024 Feb; 52(2):69-75. PubMed ID: 37937321
[TBL] [Abstract][Full Text] [Related]
3. Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
Al-Alem L; Prendergast JM; Clark J; Zarrella B; Zarrella DT; Hill SJ; Growdon WB; Pooladanda V; Spriggs DR; Cramer D; Elias KM; Nazer RI; Skates SJ; Behrens J; Dransfield DT; Rueda BR
J Ovarian Res; 2024 Apr; 17(1):71. PubMed ID: 38566237
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of blood group substances and related carbohydrate antigens in breast carcinoma.
Nakagoe T; Fukushima K; Hirota M; Kusano H; Kawahara K; Ayabe H; Tomita M; Kamihira S
Jpn J Cancer Res; 1991 May; 82(5):559-68. PubMed ID: 1905702
[TBL] [Abstract][Full Text] [Related]
5. Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.
Loureiro LR; Carrascal MA; Barbas A; Ramalho JS; Novo C; Delannoy P; Videira PA
Biomolecules; 2015 Aug; 5(3):1783-809. PubMed ID: 26270678
[TBL] [Abstract][Full Text] [Related]
6. Detection of laminin in serum and ascites from patients with epithelial ovarian tumor.
Chu Y; Yang Y; Lin M; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):58-9, 68. PubMed ID: 12658785
[TBL] [Abstract][Full Text] [Related]
7. Binding parameters of monoclonal antibodies reacting with ovarian carcinoma ascites cells.
Mattes MJ; Lloyd KO; Lewis JL
Cancer Immunol Immunother; 1989; 28(3):199-207. PubMed ID: 2924330
[TBL] [Abstract][Full Text] [Related]
8. Tn antigen promotes breast cancer metastasis via impairment of CASC4.
Li R; Dong X; Chen S; Tan J; Chen X; Liu J; Wen T; Ru X
Cell Biol Int; 2023 Nov; 47(11):1854-1867. PubMed ID: 37493437
[TBL] [Abstract][Full Text] [Related]
9. Targeting altered glycosylation in secreted tumor glycoproteins for broad cancer detection.
Kudelka MR; Gu W; Matsumoto Y; Ju T; Barnes Ii RH; Kardish RJ; Heimburg-Molinaro J; Lehoux S; Zeng J; Cohen C; Robinson BS; Shah KS; Chaikof EL; Stowell SR; Cummings RD
Glycobiology; 2023 Aug; 33(7):567-578. PubMed ID: 37216646
[TBL] [Abstract][Full Text] [Related]
10. Selective Recognition of Carbohydrate Antigens by Germline Antibodies Isolated from AID Knockout Mice.
DeLaitsch AT; Pridgen JR; Tytla A; Peach ML; Hu R; Farnsworth DW; McMillan AK; Flanagan N; Temme JS; Nicklaus MC; Gildersleeve JC
J Am Chem Soc; 2022 Mar; 144(11):4925-4941. PubMed ID: 35282679
[TBL] [Abstract][Full Text] [Related]
11. Multiple peimary cancers in patient with malignant pleural mesothelioma and ovarian serous carcinoma: A case report.
Tian D; Wang H; Zhu B; Liu H
Asian J Surg; 2024 Mar; ():. PubMed ID: 38480095
[No Abstract] [Full Text] [Related]
12. CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies.
Lodewijk I; Dueñas M; Paramio JM; Rubio C
Front Immunol; 2023; 14():1272681. PubMed ID: 37854601
[TBL] [Abstract][Full Text] [Related]
13. First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Cole CB; Morelli MP; Fantini M; Miettinen M; Fetsch P; Peer C; Figg WD; Yin T; Houston N; McCoy A; Lipkowitz S; Zimmer A; Lee JM; Pavelova M; Villanueva EN; Trewhitt K; Solarz BB; Fergusson M; Mavroukakis SA; Zaki A; Tsang KY; Arlen PM; Annunziata CM
J Exp Clin Cancer Res; 2023 Mar; 42(1):76. PubMed ID: 36991390
[TBL] [Abstract][Full Text] [Related]
14. Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201.
Tsang KY; Fantini M; Zaki A; Mavroukakis SA; Morelli MP; Annunziata CM; Arlen PM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291783
[TBL] [Abstract][Full Text] [Related]
15. Fully synthetic Mincle-dependent self-adjuvanting cancer vaccines elicit robust humoral and T cell-dependent immune responses and protect mice from tumor development.
Luo X; Lian Q; Li W; Chen L; Zhang R; Yang D; Gao L; Qi X; Liu Z; Liao G
Chem Sci; 2021 Dec; 12(48):15998-16013. PubMed ID: 35024123
[TBL] [Abstract][Full Text] [Related]
16. Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells.
Thomas D; Sagar S; Caffrey T; Grandgenett PM; Radhakrishnan P
J Cell Mol Med; 2019 Oct; 23(10):6885-6896. PubMed ID: 31389667
[TBL] [Abstract][Full Text] [Related]
17. Mucins and Truncated
Coelho R; Marcos-Silva L; Mendes N; Pereira D; Brito C; Jacob F; Steentoft C; Mandel U; Clausen H; David L; Ricardo S
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011875
[TBL] [Abstract][Full Text] [Related]
18. Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau.
Starbuck K; Al-Alem L; Eavarone DA; Hernandez SF; Bellio C; Prendergast JM; Stein J; Dransfield DT; Zarrella B; Growdon WB; Behrens J; Foster R; Rueda BR
Oncotarget; 2018 May; 9(33):23289-23305. PubMed ID: 29796189
[TBL] [Abstract][Full Text] [Related]
19. Mannosylated T/Tn with Freund's adjuvant induces cellular immunity.
Son HY; Apostolopoulos V; Kim CW
Int J Immunopathol Pharmacol; 2018; 31():394632017742504. PubMed ID: 29251002
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.
Peixoto A; Fernandes E; Gaiteiro C; Lima L; Azevedo R; Soares J; Cotton S; Parreira B; Neves M; Amaro T; Tavares A; Teixeira F; Palmeira C; Rangel M; Silva AM; Reis CA; Santos LL; Oliveira MJ; Ferreira JA
Oncotarget; 2016 Sep; 7(39):63138-63157. PubMed ID: 27542232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
